Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin’s lymphoma and multiple myeloma
Louis M Pelus1, Sherif S Farag21Department of Microbiology and Immunology, 2Division of Hematology and Oncology, Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IndianaAbstract: Multiple myeloma and non-Hodgkin’s lymphoma remain the most common ind...
Guardado en:
Autores principales: | Louis M Pelus, Sherif S Farag |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e20d375b5ff4b13812110e8f7e90885 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
por: Venugopal P, et al.
Publicado: (2011) -
Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Tian Xia, et al.
Publicado: (2021) -
Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Chitra Hosing
Publicado: (2010) -
Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
por: Satish Shanbhag, et al.
Publicado: (2010) -
Amyotrophic lateral sclerosis: applications of stem cells – an update
por: Lidia Cova, et al.
Publicado: (2010)